NCT00241436View on ClinicalTrials.gov

Open Label Arimidex in Gynecomastia

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Gynecomastia

Interventions

DRUG

Anastrozole (ARIMIDEX™)

Trial Locations (1)

Unknown

Research Site, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY